3-alkoxybenzylpiperidine derivatives as melatonergic agents
US5530012A · kind A · utility
5Cited by
11References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 1994 |
| Grant date | Jun 25, 1996 |
| Priority date | — |
| Expiry date | Dec 22, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D211/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel 3-alkoxybenzylpiperidines have melatonergic properties. They are believed useful in treating depression, jet-lag, work-shift syndrome, sleep disorders, glaucoma, some disorders associated with reproduction, cancer, immune disorders and neuroendocrine disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.